Provided by Tiger Trade Technology Pte. Ltd.

Vivos Therapeutics

0.1960
-0.0289-12.85%
Post-market: 0.1894-0.0066-3.37%19:59 EDT
Volume:532.18M
Turnover:189.80M
Market Cap:3.94M
PE:-0.11
High:0.4559
Open:0.3950
Low:0.1668
Close:0.2249
52wk High:4.63
52wk Low:0.1668
Shares:20.12M
Float Shares:18.10M
Volume Ratio:112.18
T/O Rate:2939.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8267
EPS(LYR):-2.0700
ROE:-8585.26%
ROA:-56.19%
PB:-0.80
PE(LYR):-0.09

Loading ...

Jul 10, 2024

Major Issues Report

Form 8-K - Current report
Jun 25, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Major Issues Report

Form 8-K - Current report
May 17, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2024

Major Issues Report

Form 8-K - Current report
Apr 24, 2024

Correspondence

Form CORRESP - Correspondence
Apr 22, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 09, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Mar 29, 2024

Major Issues Report

Form 8-K - Current report
Mar 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 01, 2023

Correspondence

Form CORRESP - Correspondence
Dec 01, 2023

Major Issues Report

Form 8-K - Current report
Dec 01, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Nov 22, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Nov 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]